Shanghai, China, 12 January 2024 — Recently, MicroPort® NaviBot™, an associated company of MicroPort® MedBot™, is celebrating a surge in orders for its SkyWalker™ Surgical Robot (SkyWalker™) from both Europe and America. Additionally, the company has secured bids in several hospitals in China, with a cumulative delivery of over 20 units.
Currently, SkyWalker™ has obtained approval in China, the United States, the European Union, Brazil, and Australia. It has achieved commercial breakthroughs in multiple countries and regions, performing nearly a hundred robotic procedures globally, including multiple back-to-back operations.
The global recognition of SkyWalker™ stems from its exceptional clinical performance. In November 2023, International Orthopaedics, a renowned journal, published the first large-scale clinical comparative study and related clinical data of SkyWalker™ head-to-head against a leading international surgical robot. The study showed that SkyWalker™ performed comparably to the field’s leading robot in terms of the accuracy of lower limb alignment, operation time, estimated blood loss, and results of postoperative clinical and functional knee assessment at six-month and one-year follow-ups. These findings highlight that SkyWalker™, in assisting the TKA procedure, achieves a world-class level of surgical precision and clinical efficacy.
About MicroPort® MedBot™
Founded in 2015, MicroPort® MedBot™ (Shanghai MicroPort MedBot Group Co., Ltd.; HKEX: 02252), an associated company of MicroPort® (MicroPort Scientific Corporation; HKEX: 00853), is currently the only surgical robot company in the world with businesses covering six promising subsectors of surgical robots including endoscopy, orthopedics, vascular intervention, natural orifice surgery, percutaneous puncture and medical aesthetics. MicroPort® MedBot™ is committed to meeting the growing demand for cutting-edge robotic surgery by integrating advanced research on robotics, control algorithms, electrical engineering, image-based navigation and precision imaging. MicroPort® MedBot™ provides comprehensive intelligent surgical solutions to lead the advancement of robotic surgery and shape the era of super intelligent surgery so patients everywhere can continue living better and longer lives.
More information is available at www.medbotsurgical.com/en